Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor

Lucio N. Gordan, David Ray, Stephen C. Ijioma, George Dranitsaris, Amanda Warner, Trevor Heritage, Matthew Fink, David Wenk, Paul Chadwick, Natasha Khrystolubova, Shachar Peles

Open source

DOI: 10.3390/curroncol31010034
Published: 2024-01-14
Container: Current Oncology
Publisher: MDPI AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/curroncol31010034,
  title = {Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor},
  author = {Lucio N. Gordan and David Ray and Stephen C. Ijioma and George Dranitsaris and Amanda Warner and Trevor Heritage and Matthew Fink and David Wenk and Paul Chadwick and Natasha Khrystolubova and Shachar Peles},
  year = {2024},
  journal = {Current Oncology},
  doi = {10.3390/curroncol31010034},
  url = {https://doi.org/10.3390/curroncol31010034}
}

RIS

TY  - JOUR
TI  - Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor
AU  - Lucio N. Gordan
AU  - David Ray
AU  - Stephen C. Ijioma
AU  - George Dranitsaris
AU  - Amanda Warner
AU  - Trevor Heritage
AU  - Matthew Fink
AU  - David Wenk
AU  - Paul Chadwick
AU  - Natasha Khrystolubova
AU  - Shachar Peles
PY  - 2024
JO  - Current Oncology
DO  - 10.3390/curroncol31010034
UR  - https://doi.org/10.3390/curroncol31010034
ER  -

APA

Gordan, L. N., Ray, D., Ijioma, S. C., Dranitsaris, G., Warner, A., Heritage, T., Fink, M., Wenk, D., Chadwick, P., Khrystolubova, N., & Peles, S. (2024). Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor. Current Oncology. https://doi.org/10.3390/curroncol31010034

Source records

crossref · retrieved 2026-09-25T19:25:53.055Z